Cargando…
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
A major problem in the chemotherapy of colorectal cancers is their resistance to most cytotoxic drugs which may be due to insufficient cellular transport. Drugs conjugated to monoclonal antibodies recognising tumour antigens may overcome these difficulties by providing access of active agents to the...
Autores principales: | Durrant, L. G., Garnett, M. C., Gallego, J., Armitage, N. C., Ballantyne, K. C., Marksman, R. A., Hardcastle, J. D., Baldwin, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002417/ https://www.ncbi.nlm.nih.gov/pubmed/3435698 |
Ejemplares similares
-
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989) -
Antigenicity of newly established colorectal carcinoma cell lines.
por: Durrant, L. G., et al.
Publicado: (1986) -
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
por: Durrant, L. G., et al.
Publicado: (1987) -
Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1984) -
Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1983)